Valentina Sarao

14PUBLICATIONS
31CO-AUTHORS
Optical technologyNanomedicineMedical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 06, 2026
Switching to aflibercept 8 mg in neovascular age-related macular degeneration: real-world outcomes according to switch indication.

|Feb 25, 2026
AI-assisted analysis of early fluid dynamics following aflibercept 8 mg in treatment-naïve neovascular AMD.

Daniele Veritti, Valentina Sarao, Asia Amelia Martin

|Apr 01, 2025
Early intraocular pressure dynamics following aflibercept 8 mg versus aflibercept 2 mg: a propensity score-matched analysis.

Valentina Sarao, Daniele Veritti, Francesco Bonini

|Jan 29, 2025
From pro-re-nata to fixed-interval regimen: evolving real-world treatment paradigms in anti-VEGF therapy for neovascular AMD.

Daniele Veritti, Valentina Sarao, Paolo Lanzetta

|Aug 09, 2024
Faricimab in Neovascular AMD Complicated by Pigment Epithelium Detachment: An AI-Assisted Evaluation of Early Morphological Changes.

Daniele Veritti, Valentina Sarao, Marco Gonfiantini

|Oct 13, 2023
The Present and Future of Optic Pathway Glioma Therapy.

Simone Dal Bello, Deborah Martinuzzi, Yan Tereshko

Pageof 3

Frequent Collaborators

14 joint publications

Paolo Lanzetta

12 joint publications

Daniele Veritti

2 joint publications

Jay Chhablani

1 joint publications

Valentina Soppelsa